Related Experiment Videos
Abstract:
The problems of curing tumors with a low growth fraction with cytotoxic chemotherapeutic agents include 1) the fact that such agents attack biochemical pathways common and vital to all cells, 2) the existence in a tumor of cells with both temporary and permanent resistance to specific agents, and 3) the exponential nature of cell kill, which necessitates a much more intensive treatment to effect cure than to effect remission. The possible bases for selectivity of anticancer drugs include those factors that affect the concentration of the active form of the drug at the active site, those that affect the drug receptor interaction and those that determine whether this interaction will lead to cell death. Possible ways of overcoming resistance include combination chemotherapy, more intensive chemotherapy, adjuvant chemotherapy, and maneuvers leading to recruitment of cells into cycle. Because of tumor cell heterogeneity a different approach may be needed to effect cure from that required to induce complete remission.
Insights
Achieving tumor cure with chemotherapy is challenging due to drug toxicity, cell resistance, and exponential cell kill. Overcoming tumor cell heterogeneity may require tailored treatment strategies for cure versus remission.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Cytotoxic chemotherapy faces challenges in treating tumors with low growth fractions.
- These challenges include non-specific targeting of vital cellular pathways and inherent or acquired drug resistance.
- The exponential nature of cell kill necessitates intensive treatment for cure compared to remission.
Purpose of the Study:
- To explore the fundamental problems and potential solutions in using cytotoxic chemotherapeutic agents for tumor cure.
- To identify bases for anticancer drug selectivity and strategies to overcome drug resistance.
- To address the impact of tumor cell heterogeneity on treatment outcomes.
Main Methods:
- Review of existing knowledge on chemotherapy limitations and resistance mechanisms.
- Analysis of factors influencing drug selectivity and efficacy.
- Exploration of strategies to overcome resistance, including combination and adjuvant chemotherapy.
- Consideration of cell cycle recruitment maneuvers.
Main Results:
- Anticancer drug efficacy is limited by non-specific toxicity, tumor cell resistance (temporary and permanent), and the exponential cell kill model.
- Drug selectivity can be based on factors affecting drug concentration, receptor interaction, and cell death induction.
- Strategies to overcome resistance include combination chemotherapy, dose intensification, adjuvant therapy, and cell recruitment.
Conclusions:
- Tumor cure, especially in low-growth-fraction tumors, is complex due to inherent challenges in chemotherapy.
- Understanding drug selectivity and resistance mechanisms is crucial for developing effective treatment protocols.
- Addressing tumor cell heterogeneity is essential, potentially requiring different therapeutic approaches for achieving cure versus complete remission.